Advanced Micronic Devices Peer Comparison
BSE: 517552
₹9.55
₹0.30
(3.24%)
As on 10-Dec-2018IST
Market cap
₹5 Cr
Revenue (TTM)
₹2 Cr
P/E Ratio
--
P/B Ratio
-0.1
Div. Yield
0 %
Edit
| Advanced Micronic Devices | Poly Medicure | Q-Line Biotech | Saakshi Medtech | Nureca | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
5 | 17,553 | 1,281 | 582 | 316 |
Revenue (₹ Cr) |
2 | 1,997 | 314 | 92 | 153 |
Net Profit (₹ Cr) |
-0.15 | 307.01 | 24.51 | 4.71 | 4.34 |
Net Margin (%) |
-9.40 | 14.56 | 7.60 | 5.06 | 2.70 |
RoE (%) |
-- | 10.63 | 13.94 | 4.92 | 2.29 |
Price to Earnings |
-- | 55.71 | 22.98 | 47.39 | 72.90 |
Price-To-Book |
-0.11 | 5.52 | 6.05 | 5.82 | 1.72 |
Income Statement (₹ Cr)
| Advanced Micronic Devices | Poly Medicure | Q-Line Biotech | Saakshi Medtech | Nureca | |
|---|---|---|---|---|---|
|
Operating Revenue
|
2.79 | 455.01 | -- | -- | -- |
|
Total Income
|
3.02 | 468.54 | -- | -- | -- |
|
Total Expenditure
|
17.12 | 361.54 | -- | -- | -- |
|
EBITDA
|
-14.33 | 93.46 | -- | -- | -- |
|
Depreciation
|
0.06 | 23.73 | -- | -- | -- |
|
EBIT
|
-14.39 | 69.74 | -- | -- | -- |
|
Interest
|
0.51 | 8.67 | -- | -- | -- |
|
Other Income
|
0.23 | 13.53 | -- | -- | -- |
|
Exceptional Items
|
-14.30 | -- | -- | -- | -- |
|
Profit before Tax
|
-28.96 | 75.19 | -- | -- | -- |
|
Provision for Tax
|
-- | 20.06 | -- | -- | -- |
|
Profit after Tax
|
-28.96 | 55.13 | -- | -- | -- |
Liabilities (₹ Cr)
| Advanced Micronic Devices | Poly Medicure | Q-Line Biotech | Saakshi Medtech | Nureca | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
-46.37 | 271.54 | -- | -- | -- |
|
Minority Interest
|
-- | 0.00 | -- | -- | -- |
|
Non-Current Liabilities
|
53.60 | 71.56 | -- | -- | -- |
|
Current Liabilities
|
2.05 | 113.85 | -- | -- | -- |
|
Total Liabilities
|
9.27 | 456.95 | -- | -- | -- |
Assets (₹ Cr)
| Advanced Micronic Devices | Poly Medicure | Q-Line Biotech | Saakshi Medtech | Nureca | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
4.72 | 252.03 | -- | -- | -- |
|
Current Assets
|
4.55 | 204.92 | -- | -- | -- |
|
Total Assets
|
9.27 | 456.95 | -- | -- | -- |
|
Total Debt*
|
20.34 | 100.74 | -- | -- | -- |
|
Net Current Assets
|
2.50 | 91.07 | -- | -- | -- |
|
Contingent Liabilities
|
-- | 39.19 | -- | -- | -- |
Cashflow (₹ Cr)
| Advanced Micronic Devices | Poly Medicure | Q-Line Biotech | Saakshi Medtech | Nureca | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-1.93 | 56.07 | -- | -- | -- |
|
Cash Flow from Investing Activities
|
2.11 | -55.67 | -- | -- | -- |
|
Cash from Financing Activities
|
-0.24 | -0.28 | -- | -- | -- |
|
Net Cash Inflow / Outflow
|
-0.06 | 0.11 | -- | -- | -- |
Ratios
Profitability Ratios
| Advanced Micronic Devices | Poly Medicure | Q-Line Biotech | Saakshi Medtech | Nureca | |
|---|---|---|---|---|---|
|
ROCE (%)
|
0.00 | 24.54 | -- | -- | -- |
|
ROE (%)
|
0.00 | 22.05 | -- | -- | -- |
|
ROA (%)
|
-159.04 | 13.06 | -- | -- | -- |
|
EBIT Margin (%)
|
-505.55 | 23.52 | -- | -- | -- |
|
Net Margin (%)
|
-959.19 | 11.77 | -- | -- | -- |
|
Cash Profit Margin (%)
|
-1,036.43 | 17.07 | -- | -- | -- |
Growth Ratios
| Advanced Micronic Devices | Poly Medicure | Q-Line Biotech | Saakshi Medtech | Nureca | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
2.87 | 10.37 | -- | -- | -- |
|
EBIT Growth (%)
|
31.03 | 11.43 | -- | -- | -- |
|
Net Profit Growth (%)
|
-38.79 | 16.12 | -- | -- | -- |
|
EPS Growth (%)
|
-38.79 | 14.21 | -- | -- | -- |
|
Book Value Growth (%)
|
-157.88 | 18.66 | -- | -- | -- |
Valuation Ratios
| Advanced Micronic Devices | Poly Medicure | Q-Line Biotech | Saakshi Medtech | Nureca | |
|---|---|---|---|---|---|
|
Price / Earnings
|
0.00 | 43.57 | -- | -- | -- |
|
Price / Book Value
|
-0.06 | 8.85 | -- | -- | -- |
|
Dividend Yield (%)
|
0.00 | 0.92 | -- | -- | -- |
|
EV/EBITDA
|
-1.63 | 23.17 | -- | -- | -- |
|
Market Cap (₹ Cr)
|
2.98 | 2,401.52 | -- | -- | -- |
Solvency Ratios
| Advanced Micronic Devices | Poly Medicure | Q-Line Biotech | Saakshi Medtech | Nureca | |
|---|---|---|---|---|---|
|
Debt to Equity
|
-0.44 | 0.37 | -- | -- | -- |
|
Short term debt to equity ratio
|
-0.04 | 0.12 | -- | -- | -- |
|
Current Ratio
|
2.22 | 1.80 | -- | -- | -- |
|
Quick Ratio
|
0.40 | 1.26 | -- | -- | -- |
|
Interest Coverage
|
-56.34 | 9.67 | -- | -- | -- |
Operating Efficiency Ratios
| Advanced Micronic Devices | Poly Medicure | Q-Line Biotech | Saakshi Medtech | Nureca | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
-- | 21.00 | -- | -- | -- |
|
Asset Turnover
|
0.15 | 1.09 | -- | -- | -- |
|
Receivable days
|
0.00 | 70.54 | -- | -- | -- |
|
Inventory Days
|
543.43 | 42.65 | -- | -- | -- |
|
Payable days
|
0.00 | 113.62 | -- | -- | -- |
|
Cash Conversion Cycle
|
543.43 | -0.43 | -- | -- | -- |
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
